Physician profile
Christopher I Phelps
NPI 1700075637
$2,015.81
in general payments reported to CMS, 2019-2025
11 companies · $36.95 in 2025
The $36.95 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $118 · 2020: $250 · 2021: $236 · 2022: $21.87 · 2023: $236 · 2024: $1,117 · 2025: $36.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $904 · Travel and Lodging: $487.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $903.90 |
| Travel and Lodging | $486.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,186.01 | 2023-2024 | Persona, Rosa, Synovasure Alpha Defensin |
| Pacira Therapeutics, INC. | $338.66 | 2019-2021 | |
| Bioventus LLC | $199.12 | 2020-2023 | Exogen Ultrasound Bone Healing System |
| Depuy Synthes Sales INC. | $122.16 | 2020-2025 | Monovisc |
| Stryker Corporation | $42.25 | 2019 | |
| Anika Therapeutics, INC. | $38.07 | 2024 | Tactoset, Hemicap, Integrity |
| Dentsply Sirona INC | $25.11 | 2019 | |
| Sanofi-Aventis U.S. LLC | $20.52 | 2020 | |
| Medtronic, INC. | $17.11 | 2025 | Synchromedii |
| Convatec INC. | $15.20 | 2019 | |
| Vericel Corporation | $11.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Phelps listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.